Table 4.
Index SNPs from reported GWAS studies for omega-3 and omega-6 fatty acid subtypes (Lemaitre et al. 2011; Guan et al. 2014) | SCHS meta-analysis (N = 1361) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Power | Comment | Test allele | TAF | LA | ||||||
Trait | SNP | Chr | Position | Reported gene | β | p value | ||||
LA | rs10740118 | 10 | 64771213 | JMJD1C | 15.43 | Imp | G | 0.705 | −0.009 | 0.1128 |
rs174547 | 11 | 61570783 | FADS1 | 99.99 | Typed | T | 0.338 | −0.048 | 1.12 × 10 −16* | |
rs16966952 | 16 | 15135943 | NTAN1/PDXDC1 | 32.36 | Typed | G | 0.605 | 0.009 | 0.0498* | |
GLA | rs174547 | 11 | 61570783 | FADS1 | 58.38 | Typed | T | 0.338 | −0.048 | 1.12 × 10 −16 |
rs16966952 | 16 | 15135943 | NTAN1/PDXDC1 | 12.05 | Typed | G | 0.605 | 0.009 | 0.0598 | |
DGLA | rs174547 | 11 | 61570783 | FADS1 | 99.99 | Typed | T | 0.338 | −0.048 | 1.12 × 10 −16 |
rs16966952 | 16 | 15135943 | NTAN1/PDXDC1 | 99.99 | Typed | G | 0.605 | 0.009 | 0.0598 | |
AA | rs174547 | 11 | 61570783 | FADS1 | 99.99 | Typed | T | 0.338 | −0.048 | 1.12 × 10 −16 |
rs16966952 | 16 | 15135943 | NTAN1/PDXDC1 | 60.62 | Typed | G | 0.605 | 0.009 | 0.0598 | |
Adrenic acid | rs174547 | 11 | 61570783 | FADS1 | NA | Typed | T | 0.338 | −0.048 | 1.12 × 10 −16 |
rs3134950 | 6 | 32235455 | PPT2 | NA | Imp | C | 0.411 | −0.008 | 0.1109 | |
ALA | rs174547 | 11 | 61570783 | FADS1 | 50.42 | Typed | T | 0.338 | −0.048 | 1.12 × 10 −16 |
EPA | rs3798713 | 6 | 11116608 | ELOVL2 | 40.39 | Imp | G | 0.278 | 0.005 | 0.3276 |
rs174538 | 11 | 61560081 | FADS1 | 99.99 | Typed | G | 0.342 | −0.045 | 2.22 × 10 −16 | |
rs174535 | 11 | 61551356 | FADS1 | 99.99 | Typed | T | 0.332 | −0.047 | 3.99 × 10 −16 | |
DPA | rs780094 | 2 | 27741237 | GCKR | NA | Typed | T | 0.454 | −0.014 | 0.005 |
rs3734398 | 6 | 10982973 | ELOVL2 | NA | Typed | T | 0.067 | −0.011 | 0.2521 | |
rs174547 | 11 | 61570783 | FADS1 | NA | Imp | T | 0.338 | −0.048 | 1.12 × 10 −16 | |
DHA | rs2236212 | 6 | 11103001 | ELOVL2 | 52.23 | Imp | G | 0.282 | −0.002 | 0.6754 |
Index SNPs from reported GWAS studies for omega-3 and omega-6 fatty acid subtypes (Lemaitre et al. 2011; Guan et al. 2014) | SCHS meta-analysis (N = 1361) | |||||||
---|---|---|---|---|---|---|---|---|
GLA | DGLA | DGLAa | AA | |||||
Trait | β | p value | β | p value | β | p value | β | p value |
LA | −0.003 | 0.8861 | −0.022 | 0.1284 | −0.019 | 0.4126 | −0.003 | 0.7314 |
0.523 | 1.68 × 10 −170 | 0.177 | 1.06 × 10 −29 | −0.139 | 1.46 × 10 −24 | 0.152 | 3.88 × 10 −66 | |
0.008 | 0.7179 | 0.034 | 0.0104 | 0.030 | 9.88 × 10 −4 | −0.004 | 0.6162 | |
GLA | 0.523 | 1.68 × 10 −170* | 0.177 | 1.06 × 10 −29 | −0.139 | 1.46 × 10 −24 | 0.152 | 3.88 × 10 −66 |
0.008 | 0.7179 | 0.034 | 0.0104 | 0.030 | 9.88 × 10 −4 | −0.004 | 0.6162 | |
DGLA | 0.523 | 1.68 × 10 −170 | 0.177 | 1.06 × 10−29 | −0.139 | 1.46 × 10 −24* | 0.152 | 3.88 × 10 −66 |
0.008 | 0.7179 | 0.034 | 0.0104* | 0.030 | 9.88 × 10 −4* | −0.004 | 0.6162 | |
AA | 0.523 | 1.68 × 10 −170 | 0.177 | 1.06 × 10 −29 | −0.139 | 1.46 × 10 −24 | 0.152 | 3.88 × 10 −66* |
0.008 | 0.7179 | 0.034 | 0.0104 | 0.030 | 9.88 × 10 −4 | −0.004 | 0.6162 | |
Adrenic acid | 0.523 | 1.68 × 10 −170 | 0.177 | 1.06 × 10 −29 | −0.139 | 1.46 × 10 −24 | 0.152 | 3.88 × 10 −66 |
0.013 | 0.5676 | 0.007 | 0.6049 | 0.007 | 0.5962 | 0.012 | 0.1767 | |
ALA | 0.523 | 1.68 × 10 −170 | 0.177 | 1.06 × 10 −29 | −0.139 | 1.46 × 10 −24 | 0.152 | 3.88 × 10 −66 |
EPA | 0.008 | 0.7389 | 0.006 | 0.665 | 0.006 | 0.9063 | −0.008 | 0.3949 |
0.508 | 1.74 × 10 −170 | 0.170 | 2.65 × 10 −29 | −0.132 | 2.51 × 10 −23 | 0.148 | 1.90 × 10 −63 | |
0.512 | 2.18 × 10 −170 | 0.176 | 2.79 × 10 −29 | −0.135 | 2.02 × 10 −23 | 0.151 | 1.99 × 10 −64 | |
DPA | 0.014 | 0.5094 | −0.016 | 0.2143 | −0.023 | 0.011 | −0.012 | 0.1811 |
−0.026 | 0.5481 | −0.013 | 0.6276 | −0.001 | 0.9573 | 0.002 | 0.9037 | |
0.523 | 1.68 × 10 −170 | 0.177 | 1.06 × 10 −29 | −0.139 | 1.46 × 10 −24 | 0.152 | 3.88 × 10 −66 | |
DHA | 0.001 | 0.9618 | −0.002 | 0.8946 | −0.002 | 0.9925 | −0.005 | 0.6063 |
Significant (p value <0.05) associations indicated in bold
Power indicates power in the SCHS study to detect reported associations at these SNPs given reported effect estimates (Yokoyama et al. 2007; Wang et al. 2006) and MAF of SCHS dataset; NA: power not calculated for previously reported traits that were not measured in SCHS; and TAF: test allele frequency
* Indicates significant association for same n-6 trait in the SCHS data
aDGLA trait adjusted for preceding FA level (GLA) in SCHS as this adjustment showed differences in effect estimates